arsenic has been researched along with Cardiomyopathies, Primary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| EDGE, JR | 1 |
| Prathapan, A; Raghu, KG; Soumya, RS; Vineetha, VP | 1 |
| Kobayashi, M; Naito, K; Nakamura, S; Ohnishi, K; Ohno, R; Sahara, N; Shigeno, K; Shinjo, K; Takeshita, A; Tobita, T | 1 |
| Avvisati, G; Breccia, M; Buffolino, S; Cimino, G; De Angelis, G; Lo-Coco, F; Mariella, M; Martini, V; Minotti, C | 1 |
| Bodhankar, SL; Kandhare, AD; Mukherjee, AA | 1 |
| Hietanen, E; Klockars, M; Kurppa, K; Partinen, M; Rantanen, J; Rönnemaa, T; Viikari, J | 1 |
1 review(s) available for arsenic and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Chemical exposures at work and cardiovascular morbidity. Atherosclerosis, ischemic heart disease, hypertension, cardiomyopathy and arrhythmias.
Topics: Animals; Arrhythmias, Cardiac; Arsenic; Arteriosclerosis; Cadmium; Carbon Disulfide; Carbon Monoxide; Cardiomyopathies; Cobalt; Coronary Disease; Humans; Hydrocarbons, Halogenated; Hypertension; Lead; Metals; Nitrates; Occupational Diseases; Pesticides; Polycyclic Compounds; Risk; Solvents | 1984 |
5 other study(ies) available for arsenic and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Myocardial fibrosis following arsenical therapy.
Topics: Arsenic; Arsenic Poisoning; Arsenicals; Cardiomyopathies; Heart; Myocardium | 1946 |
Arsenic trioxide toxicity in H9c2 myoblasts--damage to cell organelles and possible amelioration with Boerhavia diffusa.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium Signaling; Cardiomyopathies; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Membrane Potential, Mitochondrial; Myoblasts, Cardiac; Nyctaginaceae; Organelles; Oxidative Stress; Oxides; Plant Extracts; Plants, Medicinal; Rats; Reactive Oxygen Species | 2013 |
Two cases of acute promyelocytic leukemia complicated by torsade de pointes during arsenic trioxide therapy.
Topics: Adult; Anthracyclines; Antifungal Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cardiomyopathies; Female; Fluconazole; Humans; Hypokalemia; Leukemia, Promyelocytic, Acute; Middle Aged; Oxides; Time Factors; Torsades de Pointes | 2006 |
Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid.
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Gemtuzumab; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oncogene Proteins, Fusion; Oxides; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Tretinoin | 2007 |
Elucidation of protective efficacy of Pentahydroxy flavone isolated from Madhuca indica against arsenite-induced cardiomyopathy: Role of Nrf-2, PPAR-γ, c-fos and c-jun.
Topics: Animals; Arsenic; Cardiomyopathies; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Madhuca; NF-E2-Related Factor 2; Nitrosative Stress; Plant Extracts; Plant Leaves; PPAR gamma; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Sodium-Potassium-Chloride Symporters | 2017 |